![](/img/cover-not-exists.png)
Telavancin Hospital-Acquired Pneumonia Trials: Impact of Gram-Negative Infections and Inadequate Gram-Negative Coverage on Clinical Efficacy and All-Cause Mortality
M. K. Lacy, M. E. Stryjewski, W. Wang, T. C. Hardin, B. Nogid, D. R. Luke, A. F. Shorr, G. R. Corey, S. L. BarriereYear:
2015
Language:
english
DOI:
10.1093/cid/civ536
File:
PDF, 238 KB
english, 2015